254 related articles for article (PubMed ID: 35795208)
1. A Pyroptosis-Related Signature Predicts Overall Survival and Immunotherapy Responses in Lung Adenocarcinoma.
Zhu K; Yan A; Zhou F; Zhao S; Ning J; Yao L; Shang D; Chen L
Front Genet; 2022; 13():891301. PubMed ID: 35795208
[No Abstract] [Full Text] [Related]
2. Risk factors analysis and survival prediction model establishment of patients with lung adenocarcinoma based on different pyroptosis-related gene subtypes.
Wen Z; Pei B; Dai L; Lu P; Li X; Zhang C; Ge S
Eur J Med Res; 2023 Dec; 28(1):601. PubMed ID: 38111060
[TBL] [Abstract][Full Text] [Related]
3. A novel pyroptosis-related prognostic signature for lung adenocarcinoma: Identification and multi-angle verification.
Wang X; Zhou J; Li Z; Chen X; Wei Q; Chen K; Jiang R
Front Genet; 2023; 14():1160915. PubMed ID: 37077542
[No Abstract] [Full Text] [Related]
4. Prognostic significance of pyroptosis-related factors in lung adenocarcinoma.
Lin X; Zhou T; Hu S; Yang L; Yang Z; Pang H; Zhou X; Zhong R; Fang X; Yu Z; Hu K
J Thorac Dis; 2022 Mar; 14(3):654-667. PubMed ID: 35399245
[TBL] [Abstract][Full Text] [Related]
5. Establishment of a prognostic signature for lung adenocarcinoma by integration of 7 pyroptosis-related genes and cross-validation between the TCGA and GEO cohorts: A comprehensive bioinformatics analysis.
Zhang W; Wan S; Qu Z; Ge J; Zhang C; Li C; Jiang Y
Medicine (Baltimore); 2022 Jul; 101(29):e29710. PubMed ID: 35866781
[TBL] [Abstract][Full Text] [Related]
6. Identification of a Pyroptosis-Related Gene Signature for Predicting the Immune Status and Prognosis in Lung Adenocarcinoma.
Gong Z; Li Q; Yang J; Zhang P; Sun W; Ren Q; Tang J; Wang W; Gong H; Li J
Front Bioeng Biotechnol; 2022; 10():852734. PubMed ID: 35646872
[No Abstract] [Full Text] [Related]
7. A novel defined pyroptosis-related gene signature predicts prognosis and correlates with the tumour immune microenvironment in lung adenocarcinoma.
Chen Z; Ge L; Xu S; Li Q; Zhou L
Sci Rep; 2023 Jun; 13(1):9921. PubMed ID: 37337018
[TBL] [Abstract][Full Text] [Related]
8. A novel pyroptosis related genes signature for predicting prognosis and estimating tumor immune microenvironment in lung adenocarcinoma.
Wu C; Zhao J; Wang X; Wang Y; Zhang W; Zhu G
Transl Cancer Res; 2022 Aug; 11(8):2647-2659. PubMed ID: 36093538
[TBL] [Abstract][Full Text] [Related]
9. Identification of a Pyroptosis-Related Gene Signature for Prediction of Overall Survival in Lung Adenocarcinoma.
Dong Z; Bian L; Wang M; Wang L; Wang Y
J Oncol; 2021; 2021():6365459. PubMed ID: 34630565
[TBL] [Abstract][Full Text] [Related]
10. Subtype Classification, Immune Infiltration, and Prognosis Analysis of Lung Adenocarcinoma Based on Pyroptosis-Related Genes.
Liu Q; Fang L; Gao C; Liu C; Yu H; Wu J; Hou L; Sun C
Biomed Res Int; 2022; 2022():1371315. PubMed ID: 36277882
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Signature and Discrimination Signature of Lung Adenocarcinoma based on Pyroptosis-Related Genes.
Li GS; Lu HP; Gao L; Li JD; He RQ; Zhou HF; Chen SW; Liu J; Fu ZW; Kong JL; Zeng JH; He J; Chen G
Comb Chem High Throughput Screen; 2023; 26(2):347-361. PubMed ID: 35593363
[TBL] [Abstract][Full Text] [Related]
12. Identification and Validation of the Pyroptosis-Related Molecular Subtypes of Lung Adenocarcinoma by Bioinformatics and Machine Learning.
Liu LP; Lu L; Zhao QQ; Kou QJ; Jiang ZZ; Gui R; Luo YW; Zhao QY
Front Cell Dev Biol; 2021; 9():756340. PubMed ID: 34805165
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive genomic signature of pyroptosis-related genes and relevant characterization in hepatocellular carcinoma.
Wang S; Gao S; Shan L; Qian X; Luan J; Lv X
PeerJ; 2023; 11():e14691. PubMed ID: 36650832
[TBL] [Abstract][Full Text] [Related]
14. A Four-Gene Prognostic Signature Based on the TEAD4 Differential Expression Predicts Overall Survival and Immune Microenvironment Estimation in Lung Adenocarcinoma.
Gong X; Li N; Sun C; Li Z; Xie H
Front Pharmacol; 2022; 13():874780. PubMed ID: 35600867
[No Abstract] [Full Text] [Related]
15. Constructing novel molecular subtypes and an 11-gene signature based on pyroptosis signaling for lung adenocarcinoma.
Li L; He Q; Tao Z; Zhang R; Cui Y; Qian L
Am J Cancer Res; 2022; 12(7):3051-3066. PubMed ID: 35968341
[TBL] [Abstract][Full Text] [Related]
16. A novel and robust pyroptosis-related prognostic signature predicts prognosis and response to immunotherapy in esophageal squamous cell carcinoma.
Zhang D; Zhao F; Li J; Qin X; Li S; Niu R
Aging (Albany NY); 2023 Aug; 15(15):7811-7830. PubMed ID: 37561524
[TBL] [Abstract][Full Text] [Related]
17. Identification of N7-methylguanosine related signature for prognosis and immunotherapy efficacy prediction in lung adenocarcinoma.
Li Z; Wang W; Wu J; Ye X
Front Med (Lausanne); 2022; 9():962972. PubMed ID: 36091687
[TBL] [Abstract][Full Text] [Related]
18. Identification of lung adenocarcinoma subtypes and predictive signature for prognosis, immune features, and immunotherapy based on immune checkpoint genes.
Hua L; Wu J; Ge J; Li X; You B; Wang W; Hu B
Front Cell Dev Biol; 2023; 11():1060086. PubMed ID: 37234773
[No Abstract] [Full Text] [Related]
19. Construction and comprehensive analysis of a novel prognostic signature associated with pyroptosis molecular subtypes in patients with pancreatic adenocarcinoma.
Huang Q; Peng X; Li Q; Zhu J; Xue J; Jiang H
Front Immunol; 2023; 14():1111494. PubMed ID: 36817451
[TBL] [Abstract][Full Text] [Related]
20. Genomic and Immunological Characterization of Pyroptosis in Lung Adenocarcinoma.
Song Y; Qu Z; Feng H; Xu L; Xiao Y; Zhao Z; Wu D; Sun C; Fan X; Zhou D
J Oncol; 2022; 2022():6905588. PubMed ID: 35938142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
